MDM2 and renal cell carcinoma: Our study is the first study to link the rs2279744 genotype with RCC risk in the Taiwanese population and the first to show increased serum MDM2 levels in RCC patients as well as a significant genotype-mRNA expression in the context of RCC initiation.